Hemostasis Today
NewsFeed
Headlines Hematology Health Medicine VTE ASH Plasma Donation

Medicine

Dirk Sibbing on Antithrombotic Drugs for ACS in Women
Dec 20, 2025, 16:26 | Science
Dirk Sibbing on Antithrombotic Drugs for ACS in Women
Dirk Sibbing, Professor, Cardiologist and Angiologist at Lauterbacher Mill Private Clinic and LMU Munich, reposted…
Akshat Jain Explains VWF/FVIII Prophylaxis in Children Under 6
Dec 20, 2025, 16:13 | Insight
Akshat Jain Explains VWF/FVIII Prophylaxis in Children Under 6
Akshat Jain, Hematology Pediatric Workforce Task Force at American Society of Hematology, shared on LinkedIn:…
Manuel Requena Shares The Results of the RESISTANT International Registry
Dec 20, 2025, 15:49 | Science
Manuel Requena Shares The Results of the RESISTANT International Registry
Manuel Requena, Interventional Neurologist at Vall d'Hebron Barcelona Hospital Campus, shared in LinkedIn: ''I am…
Harshal Kale: Wishing Our Community a Bright Start to 2026
Dec 20, 2025, 13:49 | Voices
Harshal Kale: Wishing Our Community a Bright Start to 2026
Harshal Kale, Regional Program Manager - South Asia and East Asia at World Federation of…
Healthcare is a Human Right: Strengthening Blood Donation in Armenia
Dec 20, 2025, 12:23 | Insight
Healthcare is a Human Right: Strengthening Blood Donation in Armenia
Heghine Khachatryan, Editor-in-Chief of Hemostasis Today, Head of Hemophilia and Thrombosis Center at Yeolyan Hematology…
VTE Risks, Clinical Features, Diagnosis and Management Explained by Samwel Mikaye
Dec 20, 2025, 12:17 | Science
VTE Risks, Clinical Features, Diagnosis and Management Explained by Samwel Mikaye
Samwel Mikaye, CEO of SaMik Medical Center, posted on LinkedIn: "Venous Thromboembolism (VTE) refers to the formation…
Wolfgang Miesbach: Caplacizumab as Frontline Therapy for iTTP
Dec 20, 2025, 12:07 | Science
Wolfgang Miesbach: Caplacizumab as Frontline Therapy for iTTP
Wolfgang Miesbach, Professor of Medicine at Frankfurt University Hospital, shared on LinkedIn: “Caplacizumab as Frontline Therapy…
Abdul Mannan - Breaking in Haem: Andexanet Alfa Withdrawn from US Market
Dec 20, 2025, 11:13 | Drugs
Abdul Mannan - Breaking in Haem: Andexanet Alfa Withdrawn from US Market
Abdul Mannan, Consultant Haematologist at Betsi Cadwaladr University Health Board, shared on LinkedIn: "Breaking in…
Alta Schutte: Delivery Models to Improve Adherence to Medicines for Chronic Diseases in Primary Care
Dec 20, 2025, 09:24 | Science
Alta Schutte: Delivery Models to Improve Adherence to Medicines for Chronic Diseases in Primary Care
Alta Schutte, SHARP Professor of Cardiovascular Medicine at University of New South Wales, shared on…
Monitoring HHV-6 in CAR T-Cell Therapy: A Prospective Study by Emily Blyth et al.
Dec 20, 2025, 08:48 | Science
Monitoring HHV-6 in CAR T-Cell Therapy: A Prospective Study by Emily Blyth et al.
Emily Blyth, Haematologist, Clinical Lead of the Immune Effector Cell Service at Westmead Hospital, shared…
Celebrating a Year of Progress for People With Bleeding Disorders - WFH
Dec 20, 2025, 08:29 | Organizations
Celebrating a Year of Progress for People With Bleeding Disorders - WFH
WFH shared a post on X: "We’re celebrating a year of progress for people with…
Thomas Reiser: Final Day as Executive Director - Closing a Remarkable Chapter at ISTH
Dec 20, 2025, 08:14 | Voices
Thomas Reiser: Final Day as Executive Director - Closing a Remarkable Chapter at ISTH
Thomas Reiser, Executive Director at the International Society on Thrombosis and Haemostasis, shared a post…
Specific Reversal Agents for Direct Oral Anticoagulants in Neurosurgical Emergencies
Dec 20, 2025, 07:41 | Drugs
Specific Reversal Agents for Direct Oral Anticoagulants in Neurosurgical Emergencies
RPTH Journal shared a post on LinkedIn: "In emergency neurosurgery, rapid DOAC reversal is critical. This…
Amer Hayat Shares New BSH Guideline of Investigation and Management of Thrombocytosis
Dec 20, 2025, 07:19 | Insight
Amer Hayat Shares New BSH Guideline of Investigation and Management of Thrombocytosis
Amer Hayat, Hematologist at NHS Trust, shared a post on LinkedIn: "Investigation and management of thrombocytosis…
Niraj Sharma: “Successful Ablation” Does not Equal Stroke Immunity
Dec 20, 2025, 07:02 | Insight
Niraj Sharma: “Successful Ablation” Does not Equal Stroke Immunity
Niraj Sharma, Cardiac Electrophysiologist/Cardiologist at Northside Hospital, shared on LinkedIn: "Can We Really Stop Anticoagulation After…
Cardiovascular Genomics Meets Clinical Care at Cleveland Clinic
Dec 19, 2025, 23:21 | Insight
Cardiovascular Genomics Meets Clinical Care at Cleveland Clinic
Krishna Aragam, Director of Cardiovascular Genomics at Cleveland Clinic, posted on LinkedIn: ''Grateful for the…
Dato Capt. Mahesan Subramaniam: Groundbreaking Gene Therapy Wipes Out “Incurable” Leukemia in 64% of Patients
Dec 19, 2025, 23:11 | Science
Dato Capt. Mahesan Subramaniam: Groundbreaking Gene Therapy Wipes Out “Incurable” Leukemia in 64% of Patients
Dato Capt. Mahesan Subramaniam, Co-Founder of United Health Tourism, posted on LinkedIn: "Groundbreaking gene therapy wipes out…
Blood Journal New Issue on WM, Anemia, and Molecular Hematology
Dec 19, 2025, 17:21 | Science
Blood Journal New Issue on WM, Anemia, and Molecular Hematology
Blood Journals Portfolio posted on X: ''New issue of Blood out now featuring: Molecular modeling…
PPTA Europe’s Holiday Message: Wishing Health, Rest, and Renewal for 2026
Dec 19, 2025, 13:30 | Voices
PPTA Europe’s Holiday Message: Wishing Health, Rest, and Renewal for 2026
Marilena Vrana, Vice President at the Plasma Protein Therapeutics Association (PPTA) Europe, posted on LinkedIn:…
If You Were Reading a “Bible for Blood Donation Volunteers,” What’s the ONE Thing That Must Be in It?
Dec 19, 2025, 13:22 | Voices
If You Were Reading a “Bible for Blood Donation Volunteers,” What’s the ONE Thing That Must Be in It?
Dr Arun V J,The Leader of Transfusion Medicine at Malabar Medical College, shared a post on…
Julia Owens: Stroke Remains One of the World’s Leading Causes of Death and Disability
Dec 19, 2025, 12:52 | Insight
Julia Owens: Stroke Remains One of the World’s Leading Causes of Death and Disability
Julia Owens, Chief Executive Officer at Basking Biosciences Inc, reposted from Basking Biosciences, Inc. on LinkedIn:…
Alhasan Alzubi and Team on Anabolic Steroid - Associated Acute Limb Ischemia
Dec 19, 2025, 12:20 | Science
Alhasan Alzubi and Team on Anabolic Steroid - Associated Acute Limb Ischemia
Alhasan Alzubi, PGY 2 Internal Medicine Resident at Marshall University, posted on LinkedIn: ''I’m happy…
Gayatri Digambar: Safe Anticoagulation Conversion
Dec 19, 2025, 12:13 | Insight
Gayatri Digambar: Safe Anticoagulation Conversion
Gayatri Digambar, B.Pharm Finalist and Registered Pharmacist, posted on LinkedIn: ''Anticoagulation Conversion Mastering the Transition:…
Predictive Value of CRP in the General Population by Lale Tokgözoğlu and Colleagues
Dec 19, 2025, 12:08 | Insight
Predictive Value of CRP in the General Population by Lale Tokgözoğlu and Colleagues
Lale Tokgözoğlu, Professor of Cardiology at Hacettepe University, shared a post on LinkedIn: "Our new manuscript…
OCEAN Trial: Rethinking Long-term Anticoagulation after Atrial Fibrillation Ablation
Dec 19, 2025, 12:07 | Science
OCEAN Trial: Rethinking Long-term Anticoagulation after Atrial Fibrillation Ablation
Mattia Galli, Assistant Professor at Sapienza University of Rome, Associate Editor of European Heart Journal,…
Adding Aspirin to Anticoagulation Sounds Smart: The Data Says Otherwise
Dec 19, 2025, 12:05 | Insight
Adding Aspirin to Anticoagulation Sounds Smart: The Data Says Otherwise
Abdul Mannan, Consultant Haematologist at Betsi Cadwaladr University Health Board, posted on LinkedIn: ''Adding aspirin…
Pradeep Natarajan: Our New Genetic Study of Aortic Stenosis in ~3M
Dec 19, 2025, 12:03 | Science
Pradeep Natarajan: Our New Genetic Study of Aortic Stenosis in ~3M
Pradeep Natarajan, Director, Preventive Cardiology at Massachusetts General Hospital, shared on LinkedIn: ''Our new genetic…
Matthew D Neal: Most of the World is a "Platelet Desert" - Which Innovations in Platelet Transfusion Will Be an Oasis, and Which are a Mirage?
Dec 19, 2025, 11:56 | Insight
Matthew D Neal: Most of the World is a "Platelet Desert" - Which Innovations in Platelet Transfusion Will Be an Oasis, and Which are a Mirage?
Matthew D Neal, Associate Professor of Surgery, Critical Care Medicine, and Clinical and Translational Science…
Saleh Shamse Basha Attended Sysmex Europe Haemostasis Webinar About Abnormal Platelet Function Test Using LTA
Dec 19, 2025, 11:51 | Science
Saleh Shamse Basha Attended Sysmex Europe Haemostasis Webinar About Abnormal Platelet Function Test Using LTA
Saleh Shamse Basha, Senior Hematology Technologist and Hematology and Coagulation Specialist, shared a post on LinkedIn: "Attended…
ESO Blog: Anna Gardin on Stroke Risk in the Era of Climate Extremes
Dec 19, 2025, 11:47 | Voices
ESO Blog: Anna Gardin on Stroke Risk in the Era of Climate Extremes
Anna Gardin, Neurology Resident at Stroke Unit, “G. Martino” University Hospital, reposted from European Stroke…
Joshua Lin and Team: New Evidence on Long-Term Anticoagulation for Unprovoked VTE 
Dec 19, 2025, 11:45 | Science
Joshua Lin and Team: New Evidence on Long-Term Anticoagulation for Unprovoked VTE 
Joshua Lin, Executive Director of Mass General Brigham Center for Integrated Healthcare Data Research, posted…
Mohammad Alashqar in Conversation With Anticoagulation Leader Dr. Gulseth
Dec 19, 2025, 11:40 | Insight
Mohammad Alashqar in Conversation With Anticoagulation Leader Dr. Gulseth
Mohammad Alashqar, Postdoctoral Pharmacotherapy Research Fellow at The Ohio State University College of Pharmacy, posted…
MD Education Celebrates 10 Years of Global Medical Education Excellence
Dec 19, 2025, 11:39 | Organizations
MD Education Celebrates 10 Years of Global Medical Education Excellence
MD Education posted on LinkedIn: ''MD Education is celebrating 10 years. Over the past decade,…
Arterial or Atypical Clots? Think APLS, PNH, and MPN
Dec 19, 2025, 11:34 | Insight
Arterial or Atypical Clots? Think APLS, PNH, and MPN
Allison Fitzgerald, Heme/Onc Fellow at Dana-Farber, posted on X: ''Today I learned that while clots…
Gene Therapy for Hemophilia: New WFH Booklet and Webinar Released
Dec 19, 2025, 11:00 | Science
Gene Therapy for Hemophilia: New WFH Booklet and Webinar Released
World Federation of Hemophilia/Fédération mondiale de l'hémophilie posted on LinkedIn: ''Just released. The WFH’s new…
Sarah Elkourashy Presents Insights on Caplacizumab for TTP at ASH25
Dec 19, 2025, 10:51 | Insight
Sarah Elkourashy Presents Insights on Caplacizumab for TTP at ASH25
Sarah Elkourashy, Consultant in Clinical Hematology and BMT at Hamad Medical Corporation, Assistant professor of…
Camilla Lombardi Shares an EHC Nutrition Guide for People with Bleeding Disorders
Dec 19, 2025, 10:08 | Insight
Camilla Lombardi Shares an EHC Nutrition Guide for People with Bleeding Disorders
Camilla Lombardi, Communication and Project Officer at EHC - European Haemophilia Consortium, reposted from EHC…
Danny Hsu Shares The ''I-WISh'' Study by Nichola Cooper on ITP
Dec 19, 2025, 09:56 | Science
Danny Hsu Shares The ''I-WISh'' Study by Nichola Cooper on ITP
Danny Hsu, President of THANZ, reposted from ITP Australia and New Zealand on LinkedIn: ''Burden of…
Paul Bolaji: A Landmark Achievement -The Historic 1st Nigerian Stroke Leaders’ Summit 2025
Dec 19, 2025, 09:39 | Insight
Paul Bolaji: A Landmark Achievement -The Historic 1st Nigerian Stroke Leaders’ Summit 2025
Paul Bolaji, Education Lead (Stroke Services) at Dorset County Hospital NHS Foundation Trust, shared on…
Zain Khalpey on A New Study Linking Low-dose Aspirin to Reduced Cancer Spread
Dec 19, 2025, 09:24 | Science
Zain Khalpey on A New Study Linking Low-dose Aspirin to Reduced Cancer Spread
Zain Khalpey, Adjunct Assistant Professor of Surgery at Columbia University Irving Medical Center, shared on…
Anna Aldehag Reflects on Her 12 Year Leadership in Sweden National Board of Health and Welfare
Dec 19, 2025, 06:13 | Voices
Anna Aldehag Reflects on Her 12 Year Leadership in Sweden National Board of Health and Welfare
Anna Aldehag, Head of Unit of National Donation Center at Stockholm County, shared on LinkedIn:…
Abdul Mannan: APTT Mixing Studies Confuse a Lot of People
Dec 19, 2025, 05:54 | Insight
Abdul Mannan: APTT Mixing Studies Confuse a Lot of People
Abdul Mannan, Consultant Haematologist at Betsi Cadwaladr University Health Board, shared on LinkedIn: ''APTT mixing…
Maxime Dely: What If One Technology Could Transform Patients' Lives?
Dec 18, 2025, 23:56 | Insight
Maxime Dely: What If One Technology Could Transform Patients' Lives?
Maxime Dely, Sales and Application Specialist in Therapeutic Apheresis and Cell Therapy, shared a post on LinkedIn:…
Why O-Negative Blood Is Not for Everyone - A Critical Transfusion Myth
Dec 18, 2025, 23:49 | Insight
Why O-Negative Blood Is Not for Everyone - A Critical Transfusion Myth
Ravi Dara, Consultant Physician, Transfusion Medicine at Sheikh Shakhbout Medical City - SSMC, shared a…
Ben Zaranko and Colleagues Published: Nursing Shortages and Patient Outcomes
Dec 18, 2025, 23:32 | Science
Ben Zaranko and Colleagues Published: Nursing Shortages and Patient Outcomes
Ben Zaranko, Associate Director at Institute for Fiscal Studies, shared a post on X: "A short…
José Antonio García Erce Made His 7th Donation of Plasmaferesis: Anything Better Than Doing for Others?
Dec 18, 2025, 23:27 | Voices
José Antonio García Erce Made His 7th Donation of Plasmaferesis: Anything Better Than Doing for Others?
José Antonio García Erce, Director of the Donation Center, Navarre Health Service (Osasunbidea), posted on LinkedIn: "PLASMAPHERESIS…
Michael Makris: Excellent Article in This Week's NEJM Explains Word Estimand Clearly
Dec 18, 2025, 23:25 | Science
Michael Makris: Excellent Article in This Week's NEJM Explains Word Estimand Clearly
Michael Makris, Emeritus Professor of Haemostasis and Thrombosis at the University of Sheffield, Editor-in-Chief of…
Wolfgang Miesbach: Predicting Breakthrough Bleeding in Emicizumab-Treated Acquired Haemophilia A
Dec 18, 2025, 23:23 | Science
Wolfgang Miesbach: Predicting Breakthrough Bleeding in Emicizumab-Treated Acquired Haemophilia A
Wolfgang Miesbach, Professor of Medicine at Frankfurt University Hospital, shared on LinkedIn: "Predicting Breakthrough Bleeding in…
Dr Ana-Mishel (AM) Spiroski Shares Ziad Mallat's Article: Translating Nobel Prize-Winning Treg Cell Science Into Cardiovascular Therapy
Dec 18, 2025, 23:22 | Insight
Dr Ana-Mishel (AM) Spiroski Shares Ziad Mallat's Article: Translating Nobel Prize-Winning Treg Cell Science Into Cardiovascular Therapy
Dr Ana-Mishel (AM) Spiroski, Cardiovascular TA Lead, Age-Related Diseases TA Lead, Group Leader, In Vivo…
The "Normal" FVIII Level Trap in Females with Haemophilia
Dec 18, 2025, 23:14 | Science
The "Normal" FVIII Level Trap in Females with Haemophilia
Wolfgang Miesbach, Professor of Medicine at Frankfurt University Hospital, posted on LinkedIn: ''The "Normal" FVIII…
WFH Expands Multidisciplinary Bleeding Disorder Training in Vietnam
Dec 18, 2025, 23:11 | Organizations
WFH Expands Multidisciplinary Bleeding Disorder Training in Vietnam
World Federation of Hemophilia/Fédération mondiale de l'hémophilie posted on LinkedIn: '' The WFH team visited…
Daria Camilli on EuroBloodNet and EHC Collaboration for Bleeding Disorders
Dec 18, 2025, 17:13 | Insight
Daria Camilli on EuroBloodNet and EHC Collaboration for Bleeding Disorders
Daria Camilli, Education and Communication Manager at EHC - European Haemophilia Consortium, reposted from ERN-EuroBloodNet…
Marie Cambot on Innovhem's Quantification of The HbF/HbS Ratio for SCD
Dec 18, 2025, 16:50 | Voices
Marie Cambot on Innovhem's Quantification of The HbF/HbS Ratio for SCD
Marie Cambot, Co founder and CEO at INNOVHEM, reposted from INNOVHEM on LinkedIn: ''Many thanks to…
Yogesh Rathod on Hematological Issues and ICU
Dec 18, 2025, 16:26 | Insight
Yogesh Rathod on Hematological Issues and ICU
Yogesh Rathod, Director at Aadhar Critical Care, shared on LinkedIn: ''Hematological Issues and ICU Hematological…
Carlos Doti: I’m Reminded Why ASH is Such a Powerful Close to The Year
Dec 18, 2025, 16:09 | Insight
Carlos Doti: I’m Reminded Why ASH is Such a Powerful Close to The Year
Carlos Doti, VP US Medical Affairs Oncology at AstraZeneca, shared on LinkedIn: ''As I reflect…
Michael Hadley: Well-Timed ACC Statement Just Out in JACC Journals
Dec 18, 2025, 15:23 | Science
Michael Hadley: Well-Timed ACC Statement Just Out in JACC Journals
Michael Hadley, System Director of Advanced Cardiac Imaging at Northwell Health, shared on LinkedIn: ''Well-timed…
Wolfgang Miesbach on Insights from Guy Young's ASH2025 Session on Next-Generation Gene Therapy
Dec 18, 2025, 15:12 | Insight
Wolfgang Miesbach on Insights from Guy Young's ASH2025 Session on Next-Generation Gene Therapy
Wolfgang Miesbach, Professor of Medicine at Frankfurt University Hospital, shared on LinkedIn: ''The Immunogenicity Challenge…
Plasma-Derived Therapy for Hemophilia in The Updated European Medicines Agency’s Union List
Dec 18, 2025, 14:15 | Drugs
Plasma-Derived Therapy for Hemophilia in The Updated European Medicines Agency’s Union List
Deborah Hibbett, Senior Vice President, Head of Global Corporate Affairs and Sustainability, Plasma-Derived Therapies at…
Laurent Bertoletti: BAT-VTE is One of 7 Projects Funded Under the EFFECT Trial Call!
Dec 18, 2025, 13:55 | Insight
Laurent Bertoletti: BAT-VTE is One of 7 Projects Funded Under the EFFECT Trial Call!
Laurent Bertoletti, University Professor and Hospital Practitioner at Jean Monnet University, Saint-Etienne, shared on LinkedIn:…
Alexandru Stieber Explores VEXAS Syndrome
Dec 18, 2025, 13:34 | Insight
Alexandru Stieber Explores VEXAS Syndrome
Alexandru Stieber, Internal Medicine Resident at SUUMC Bucharest, shared on LinkedIn: ''Second set of scientific…
Dr. Tareq Abadl: How to Tell When a Transfusion Suddenly Goes Wrong
Dec 18, 2025, 13:34 | Insight
Dr. Tareq Abadl: How to Tell When a Transfusion Suddenly Goes Wrong
Dr. Tareq Abadl, Medical Laboratory Specialist and Director of the Blood Bank at Dr. Abdelkader…
Reza Shojaei: Public–Private Partnerships are Essential to Expanding Plasma Collection Capacity
Dec 18, 2025, 13:33 | Science
Reza Shojaei: Public–Private Partnerships are Essential to Expanding Plasma Collection Capacity
Reza Shojaei, Chief Operating Officer at Canadian Plasma Resources, shared on LinkedIn: "This article highlights Canadian…
Dr. Deepthi Krishna was Part of ISTM-Transmedocon and Awarded the 3rd Prize in the Oral Paper Category
Dec 18, 2025, 13:30 | Insight
Dr. Deepthi Krishna was Part of ISTM-Transmedocon and Awarded the 3rd Prize in the Oral Paper Category
Dr. Deepthi Krishna, Consultant, Department of Transfusion Medicine at Rela Hospital, posted on LinkedIn: "Privileged to…
Paul-Ehrlich-Institut Collected and Reported The Blood Supply Situation for 2024
Dec 18, 2025, 13:27 | Insight
Paul-Ehrlich-Institut Collected and Reported The Blood Supply Situation for 2024
Paul-Ehrlich-Institut shared a post on LinkedIn: "Blood, blood products and stem cell preparations are indispensable for…
Niraj Sharma: Can We Really Stop Anticoagulation After AF Ablation?
Dec 18, 2025, 12:12 | Insight
Niraj Sharma: Can We Really Stop Anticoagulation After AF Ablation?
Niraj Sharma, Cardiac Electrophysiologist/Cardiologist at Northside Hospital, shared on LinkedIn: ''Can We Really Stop Anticoagulation…
Eric Topol: A Single Infusion That Erases Decades of Hemophilia
Dec 18, 2025, 04:03 | Insight
Eric Topol: A Single Infusion That Erases Decades of Hemophilia
Eric Topol, Founder and Director of Scripps Research Translational Institute, shared on X: " 'I had hemophilia…
Jim Hoffman: Uncontrolled Neutrophil Activation and NET Release in the Vasculature
Dec 17, 2025, 23:59 | Science
Jim Hoffman: Uncontrolled Neutrophil Activation and NET Release in the Vasculature
Jim Hoffman, Former Technical Advisor at Cygnus Technologies, LLC, posted on LinkedIn: " 'We observe extensive spontaneous…
Dr. Arun V. J: The Most Dangerous Thing in a Blood Bank is a "Reluctant" Donor
Dec 17, 2025, 23:58 | Voices
Dr. Arun V. J: The Most Dangerous Thing in a Blood Bank is a "Reluctant" Donor
Dr. Arun V. J, Member of ADRP (The Association for Blood Donor Professionals), shared a…
Wolfgang Miesbach: Rituximab Dose Optimization in iTTP - Why Standard Dose is Preferred?
Dec 17, 2025, 23:55 | Drugs
Wolfgang Miesbach: Rituximab Dose Optimization in iTTP - Why Standard Dose is Preferred?
Wolfgang Miesbach, Professor of Medicine at Frankfurt University Hospital, shared on LinkedIn: "ASH25 Data: Rituximab Dose…
Heghine Khachatryan: The Hemophilia Landscape in Armenia has Changed Dramatically - For the Better
Dec 17, 2025, 23:53 | Voices
Heghine Khachatryan: The Hemophilia Landscape in Armenia has Changed Dramatically - For the Better
Heghine Khachatryan, Editor-in-Chief of Hemostasis Today, Head of Hemophilia and Thrombosis Center at Yeolyan Hematology…
WFH: Strengthening Collaboration With the Ecuadorian Bleeding Disorders Community
Dec 17, 2025, 23:38 | Organizations
WFH: Strengthening Collaboration With the Ecuadorian Bleeding Disorders Community
World Federation of Hemophilia (WFH) shared on LinkedIn: ”The WFH recently visited Ecuador to meet with representatives…
Sunil Kumar: Top 10 Drugs Driving Revenue in Rare Disease Therapeutics (2024)
Dec 17, 2025, 23:37 | Insight
Sunil Kumar: Top 10 Drugs Driving Revenue in Rare Disease Therapeutics (2024)
Sunil Kumar, Entrepreneur of Medifit Devices LLP, shared a post on LinkedIn: "Top 10 Drugs…
Jacqui McCallum: Best Decision I Made in 2025? Joining Team Stroke
Dec 17, 2025, 23:28 | Voices
Jacqui McCallum: Best Decision I Made in 2025? Joining Team Stroke
Jacqui McCallum, Executive Director, Brand, Communications and Advocacy at the Stroke Foundation, shared a post…
Gevorg Tamamyan: We Can Do More...
Dec 17, 2025, 23:14 | Voices
Gevorg Tamamyan: We Can Do More...
Gevorg Tamamyan, Editor-in-Chief and Co-Founder of OncoDaily, shared on LinkedIn: ''Coming from the developing world,…
David Clement: From Controversy to Canada’s Paid Plasma Model
Dec 17, 2025, 23:06 | Insight
David Clement: From Controversy to Canada’s Paid Plasma Model
David Clement, North American Affairs Manager at Consumer Choice Center, posted on LinkedIn: ''In 2018,…
Lidia Schapira: Finding Smart Discussion Groups - Why I Joined Roon
Dec 17, 2025, 22:42 | Organizations
Lidia Schapira: Finding Smart Discussion Groups - Why I Joined Roon
Lidia Schapira, Professor of Medicine at Stanford, shared a post on LinkedIn: "Where can we…
Jean-Michel Dogné: 11 Clinical Trials that Will Shape Medicine in 2026 According to Nature Medicine
Dec 17, 2025, 22:06 | Insight
Jean-Michel Dogné: 11 Clinical Trials that Will Shape Medicine in 2026 According to Nature Medicine
Jean-Michel Dogné, Dean of the Faculty of Medicine at Université de Namur, shared a post on…
Ton Lisman Invites You to the 10th International Congress on Coagulopathy in Liver Diseases
Dec 17, 2025, 20:31 | Insight
Ton Lisman Invites You to the 10th International Congress on Coagulopathy in Liver Diseases
Ton Lisman, Professor of Experimental Surgery at UMC Groningen, shared on LinkedIn: ''From April 8-10,…
Laura Dormer on a Motor Relearning Program for Chronic Stroke Patients
Dec 17, 2025, 15:24 | Science
Laura Dormer on a Motor Relearning Program for Chronic Stroke Patients
Laura Dormer, Co-Founder and Editorial Director at Becaris Publishing, shared on LinkedIn: ''New article alert…
WSO: United Nations Has Formally Adopted the Political Declaration on NCDs and Mental Health
Dec 17, 2025, 15:01 | Insight
WSO: United Nations Has Formally Adopted the Political Declaration on NCDs and Mental Health
World Stroke Organization (WSO) shared on LinkedIn: ''A major step forward for global health We…
Bryan Unger: 1st Patient Has Been Enrolled in NuvOx Therapeutics’ Phase IIb NOVEL Trial
Dec 17, 2025, 14:44 | Insight
Bryan Unger: 1st Patient Has Been Enrolled in NuvOx Therapeutics’ Phase IIb NOVEL Trial
Bryan Unger, Director of Business Development at Microvascular Therapeutics, reposted from NuvOx Therapeutics on LinkedIn: ''Proud…
Sarah Richardson: Feeling So Proud to Be a Part of the Advocacy Team for the HFA
Dec 17, 2025, 14:29 | Voices
Sarah Richardson: Feeling So Proud to Be a Part of the Advocacy Team for the HFA
Sarah Richardson, Information Technology Administrator at ABR Systems Group, shared on LinkedIn: ''Feeling so proud…
Wolfgang Miesbach on Linus Völker's Presentation of Caplacizumab as Frontline Therapy for iTTP
Dec 17, 2025, 06:28 | Insight
Wolfgang Miesbach on Linus Völker's Presentation of Caplacizumab as Frontline Therapy for iTTP
Wolfgang Miesbach, Professor of Medicine at Frankfurt University Hospital, shared on LinkedIn: ''Caplacizumab as Frontline…
Lisa Murphy Thanks Stroke Foundation Team for An Impactful, Rewarding and Incredible Year
Dec 17, 2025, 06:11 | Insight
Lisa Murphy Thanks Stroke Foundation Team for An Impactful, Rewarding and Incredible Year
Lisa Murphy, Chief Executive Officer at Stroke Foundation, shared on LinkedIn: ''A final celebration from…
Emmanuel J Favaloro Shares A Study on AI and Machine Learning in Thrombosis and Hemostasis
Dec 17, 2025, 06:05 | Science
Emmanuel J Favaloro Shares A Study on AI and Machine Learning in Thrombosis and Hemostasis
Emmanuel J Favaloro, Lead Scientist at the Sydney Centres for Thrombosis and Haemostasis, Westmead Hospital,…
Michael Bruckman: Fantastic to See Platelet-Inspired Nanoparticles Gaining Attention!
Dec 17, 2025, 05:54 | Drugs
Michael Bruckman: Fantastic to See Platelet-Inspired Nanoparticles Gaining Attention!
Michael Bruckman, CEO at Haima Therapeutics, shared on LinkedIn: ''Fantastic to see platelet-inspired nanoparticles gaining…
Comparison of LTA in Patients with Bleeding Disorder of Unknown Cause and Healthy Blood Donors - Now on RPTH Journal
Dec 17, 2025, 04:04 | Science
Comparison of LTA in Patients with Bleeding Disorder of Unknown Cause and Healthy Blood Donors - Now on RPTH Journal
RPTH Journal shared a post on LinkedIn: "A new study reassesses guideline-recommended agonist concentrations for light…
Our Editorial Fellowship Gives You Behind-the-Scenes Access to Peer Review and More - Blood Journals Portfolio
Dec 17, 2025, 04:03 | Insight
Our Editorial Fellowship Gives You Behind-the-Scenes Access to Peer Review and More - Blood Journals Portfolio
Blood Journals Portfolio shared a post on X: "Curious about what happens after a manuscript is…
Peter Verhamme on Genetic Predisposition to Thromboembolism and COVID
Dec 17, 2025, 04:00 | Science
Peter Verhamme on Genetic Predisposition to Thromboembolism and COVID
Peter Verhamme, Associate Professor at KU Leuven, shared on LinkedIn: ''A paper with a story,…
Shrinidhi Nathany: MRD in AML - From a Test to a Treatment Decision
Dec 16, 2025, 23:14 | Insight
Shrinidhi Nathany: MRD in AML - From a Test to a Treatment Decision
Shrinidhi Nathany, Consultant Molecular Hematology and Oncology at Fortis Memorial, posted on LinkedIn: “MRD in AML: From…
Jim Hoffman: Timely Extracorporeal NET Removal Therapy Should Be Tried on High-Risk Patients
Dec 16, 2025, 23:04 | Science
Jim Hoffman: Timely Extracorporeal NET Removal Therapy Should Be Tried on High-Risk Patients
Jim Hoffman, Technical Advisor at Cygnus Technologies, LLC, reposted  from  Jocelyn M. on LinkedIn: “We…
Wolfgang Miesbach - Targeting VEGF to Stop GI Bleeding: Systemic Bevacizumab
Dec 16, 2025, 22:16 | Drugs
Wolfgang Miesbach - Targeting VEGF to Stop GI Bleeding: Systemic Bevacizumab
Wolfgang Miesbach, Professor of Medicine at Frankfurt University Hospital, shared on LinkedIn: "Targeting VEGF to Stop…
Piotr Czempik Honored for His Work on Cost Reduction in Blood Transfusions
Dec 16, 2025, 17:14 | Insight
Piotr Czempik Honored for His Work on Cost Reduction in Blood Transfusions
Piotr Czempik, Chair of Department of Anesthesiology and Intensive Care at Medical University of Silesia,…
Davood KHoda Amorzideh on VTE and Bleeding in Cancer
Dec 16, 2025, 17:06 | Science
Davood KHoda Amorzideh on VTE and Bleeding in Cancer
Davood KHoda Amorzideh, Clinical Cardiologist at Farjam Heart Clinic, shared on LinkedIn: ''In the AVERT…
Kathryn Mikkelsen on The Beat: Vasculearn Network's Newsletter for Clot Survivors
Dec 16, 2025, 16:56 | Insight
Kathryn Mikkelsen on The Beat: Vasculearn Network's Newsletter for Clot Survivors
Kathryn Mikkelsen, Executive Director at Vasculearn Network, shared on LinkedIn: ''Ever find yourself thinking, “I…
Raul Santos on Sex-Specific Biology and Plasma Fructose Levels in Cardiovascular Risk
Dec 16, 2025, 16:50 | Science
Raul Santos on Sex-Specific Biology and Plasma Fructose Levels in Cardiovascular Risk
Raul Santos, Researcher at ARO Hospital Israelita Albert Einstein, shared on LinkedIn: ''Happy to share…
Mads Krogsgaard Thomsen on Novo Nordisk Haemophilia Foundation's Support for Haemoglobinopathies
Dec 16, 2025, 16:34 | Insight
Mads Krogsgaard Thomsen on Novo Nordisk Haemophilia Foundation's Support for Haemoglobinopathies
Mads Krogsgaard Thomsen, CEO at Novo Nordisk Foundation, shared on LinkedIn: ''Haemophilia and other blood…
Leonardo Furtado Freitas Presents a Rare Hemorrhagic Hemangioblastoma Case
Dec 16, 2025, 16:22 | Science
Leonardo Furtado Freitas Presents a Rare Hemorrhagic Hemangioblastoma Case
Leonardo Furtado Freitas, Clinical Associate Professor of Neuroradiology at Florida International University, shared on LinkedIn:…
Nicolas Gendron on Sustainability in Anticoagulation and DOACs
Dec 16, 2025, 16:14 | Science
Nicolas Gendron on Sustainability in Anticoagulation and DOACs
Nicolas Gendron, Research Fellow, Hematologist at Boston Children’s Hospital, shared on LinkedIn: ''Anticoagulation and sustainability.…
Reza Shojaei: Every Expired Unit of Blood Tells a Story
Dec 16, 2025, 15:39 | Insight
Reza Shojaei: Every Expired Unit of Blood Tells a Story
Reza Shojaei, Chief Operating Officer at Canadian Plasma Resources, shared on LinkedIn: ''Every expired unit…
All: 3463 Posts: 601 - 700
NewsFeed